Goodrx Share Price (NASDAQ: GDRX)

$4.36

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Goodrx Stock chart to analyse performance

Goodrx stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$4.27
Today's High:$4.36
$4.36
2.18%
Downside
Day's Volatility :2.18%
Upside
0.0%
52 Weeks Low:$3.31
52 Weeks High:$8.22
$4.36
24.2%
Downside
52 Weeks Volatility :59.79%
Upside
46.96%

Goodrx Stock Returns

Period	Goodrx Holdings, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	14.01%	3.6%	0.0%
6 Months	-10.21%	-7.7%	0.0%
1 Year	-44.59%	-12.6%	0.0%
3 Years	-23.6%	9.5%	-4.7%

Goodrx Holdings, Inc. Key Stats

Check Goodrx key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$4.36
Open	$4.34
Today's High	$4.36
Today's Low	$4.265
Market Capitalization	$1.6B
Today's Volume	$1.6M
52 Week High	$8.22
52 Week Low	$3.305
Revenue TTM	$799.9M
EBITDA	$134.6M
Earnings Per Share (EPS)	$0.09
PE Ratio	48.44
Profit Margin	4.33%
Quarterly Earnings Growth YOY	1.02%
Return On Equity TTM	5.27%

Stock Returns calculator for Goodrx Stock including INR - Dollar returns

The Goodrx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Goodrx investment value today

Current value as on today

₹60,474

Returns

₹39,526

(-39.53%)

Returns from Goodrx Stock

₹44,810 (-44.81%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Goodrx Stock

28%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Goodrx Stock from India on INDmoney has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Goodrx Holdings, Inc.

Name
Holdings %
Name
Holdings %
Francisco Partners Management LP
17.29%
Vanguard Group Inc
2.47%
Ameriprise Financial Inc
1.33%
Lakewood Capital Management, LP
1.20%
SILVER LAKE GROUP, L.L.C.
1.02%
Petrus Trust Company, LTA
0.89%

Analyst Recommendation on Goodrx Stock

Rating

Trend

Buy

57%Buy

38%Hold

3%Sell

Based on 26 Wall street analysts offering stock ratings for Goodrx(by analysts ranked 0 to 5 stars)

Goodrx Share Price Target

What analysts predicted

Upside of 23.12%

Target:

$5.37

Current:

$4.36

Goodrx share price target is $5.37, a slight Upside of 23.12% compared to current price of $4.36 as per analysts' prediction.

Goodrx Stock Insights

Price Movement
In the last 7 days, GDRX stock has moved down by -4.5%
Increasing Revenue
Revenue is up for the last 4 quarters, 195.25M → 203.07M (in $), with an average increase of 1.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 6.74M → 12.84M (in $), with an average increase of 26.5% per quarter
GDRX vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 84.7% return, outperforming this stock by 129.6%
GDRX vs DOCS (3 yr)
In the last 3 years, Doximity, Inc. has given 108.5% return, outperforming this stock by 137.7%
Price to Sales
ForGDRX every $1 of sales, investors are willing to pay $2.1, whereas for Doximity, Inc., the investors are paying $21.6 for every $1 of sales.

Goodrx Holdings, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$388.2M	↑ 55.59%
Net Income	$66.0M	↑ 50.82%
Net Profit Margin	17.01%	↓ 0.54%

	FY20	Y/Y Change
Revenue	$550.7M	↑ 41.85%
Net Income	$-293.6M	↓ 544.56%
Net Profit Margin	-53.32%	↓ 70.33%

	FY21	Y/Y Change
Revenue	$745.4M	↑ 35.36%
Net Income	$-25.3M	↓ 91.4%
Net Profit Margin	-3.39%	↑ 49.93%

	FY22	Y/Y Change
Revenue	$766.6M	↑ 2.83%
Net Income	$-32.8M	↑ 29.99%
Net Profit Margin	-4.28%	↓ 0.89%

	FY23	Y/Y Change
Revenue	$750.3M	↓ 2.12%
Net Income	$-8.9M	↓ 72.99%
Net Profit Margin	-1.18%	↑ 3.1%

	FY24	Y/Y Change
Revenue	$792.3M	↑ 5.61%
Net Income	$16.4M	↓ 284.82%
Net Profit Margin	2.07%	↑ 3.25%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$197.9M	↑ 0.63%
Net Income	$-1.0M	↓ 96.1%
Net Profit Margin	-0.51%	↑ 12.65%

	Q2 FY24	Q/Q Change
Revenue	$200.6M	↑ 1.38%
Net Income	$6.7M	↓ 763.43%
Net Profit Margin	3.34%	↑ 3.85%

	Q3 FY24	Q/Q Change
Revenue	$195.3M	↓ 2.67%
Net Income	$12.3M	↑ 83.13%
Net Profit Margin	6.28%	↑ 2.94%

	Q4 FY24	Q/Q Change
Revenue	$198.6M	↑ 1.71%
Net Income	$6.7M	↓ 45.02%
Net Profit Margin	3.39%	↓ 2.89%

	Q1 FY25	Q/Q Change
Revenue	$203.0M	↑ 2.21%
Net Income	$11.1M	↑ 63.98%
Net Profit Margin	5.45%	↑ 2.06%

	Q2 FY25	Q/Q Change
Revenue	$203.1M	↑ 0.05%
Net Income	$12.8M	↑ 16.21%
Net Profit Margin	6.32%	↑ 0.87%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$374.2M	↑ 53.69%

	FY20	Y/Y Change
Profit	$521.1M	↑ 39.26%

	FY21	Y/Y Change
Profit	$698.7M	↑ 34.08%

	FY22	Y/Y Change
Profit	$701.5M	↑ 0.4%

	FY23	Y/Y Change
Profit	$683.3M	↓ 2.59%

	FY24	Y/Y Change
Profit	$744.1M	↑ 8.89%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$169.5M	↑ 21.8%

	Q2 FY24	Q/Q Change
Profit	$171.8M	↑ 1.36%

	Q3 FY24	Q/Q Change
Profit	$183.6M	↑ 6.86%

	Q4 FY24	Q/Q Change
Profit	$186.4M	↑ 1.54%

	Q1 FY25	Q/Q Change
Profit	$189.6M	↑ 1.73%

	Q2 FY25	Q/Q Change
Profit	$170.0M	↓ 10.35%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$83.3M	↑ 84.05%
Investing Cash Flow	$-37.1M	↑ 971.57%
Financing Cash Flow	$-54.8M	↑ 121.48%

	FY20	Y/Y Change
Operating Cash Flow	$131.3M	↑ 57.7%
Investing Cash Flow	$-91.6M	↑ 147.25%
Financing Cash Flow	$905.8M	↓ 1753.52%

	FY21	Y/Y Change
Operating Cash Flow	$178.8M	↑ 36.12%
Investing Cash Flow	$-178.7M	↑ 95.09%
Financing Cash Flow	$-30.5M	↓ 103.37%

	FY22	Y/Y Change
Operating Cash Flow	$146.8M	↓ 17.9%
Investing Cash Flow	$-210.5M	↑ 17.77%
Financing Cash Flow	$-120.2M	↑ 293.82%

	FY23	Y/Y Change
Operating Cash Flow	$138.3M	↓ 5.78%
Investing Cash Flow	$-55.8M	↓ 73.51%
Financing Cash Flow	$-167.4M	↑ 39.23%

	FY24	Y/Y Change
Operating Cash Flow	$183.9M	↑ 32.97%
Investing Cash Flow	$-70.3M	↑ 26.15%
Financing Cash Flow	$-337.5M	↑ 101.62%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$42.6M	↑ 168.38%
Investing Cash Flow	$-20.6M	↑ 60.15%
Financing Cash Flow	$-161.0M	↑ 28.16%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$9.7M	↓ 77.22%
Investing Cash Flow	$-17.2M	↓ 16.42%
Financing Cash Flow	$-864.0K	↓ 99.46%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$86.9M	↑ 795.39%
Investing Cash Flow	$-15.9M	↓ 7.95%
Financing Cash Flow	$-172.1M	↑ 19822.34%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$44.7M	↓ 48.49%
Investing Cash Flow	$-16.6M	↑ 4.95%
Financing Cash Flow	$-3.5M	↓ 97.95%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$9.4M	↓ 78.96%
Investing Cash Flow	$-51.9M	↑ 211.68%
Financing Cash Flow	$-104.9M	↑ 2871.73%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$49.6M	↑ 426.72%
Investing Cash Flow	$-18.3M	↓ 64.69%
Financing Cash Flow	$-50.9M	↓ 51.45%

Goodrx Technicals Summary

Sell

Neutral

Buy

Goodrx is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Goodrx Holdings, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Goodrx Holdings, Inc.	-3.86%	-10.21%	-44.59%	-23.6%	-91.38%
Tempus Ai	38.06%	48.79%	45.48%	88.27%	88.27%
Doximity, Inc.	18.52%	-0.73%	89.28%	107.86%	28.21%
Ge Healthcare Technologies Inc.	5.57%	-14.7%	-13.04%	21.9%	21.9%
Veeva Systems Inc.	-4.29%	22.99%	24.82%	57.09%	-8.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Goodrx Holdings, Inc.	48.44	48.44	NA	0.38	0.05	0.05	NA	1.84
Tempus Ai	34.26	34.26	NA	-0.73	-0.98	-0.12	NA	1.78
Doximity, Inc.	57.96	57.96	2.42	1.31	0.24	0.13	NA	5.47
Ge Healthcare Technologies Inc.	15.11	15.11	3.44	4.51	0.26	0.06	0.0	21.27
Veeva Systems Inc.	55.28	55.28	1.4	6.45	0.14	0.07	NA	40.6

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Goodrx Holdings, Inc.	Buy	$1.6B	-91.38%	48.44	4.33%
Tempus Ai	NA	$12.8B	88.27%	34.26	-20.98%
Doximity, Inc.	Hold	$12.7B	28.21%	57.96	39.88%
Ge Healthcare Technologies Inc.	Buy	$33.9B	21.9%	15.11	11.22%
Veeva Systems Inc.	Buy	$44.0B	-8.43%	55.28	27.29%

About Goodrx Holdings, Inc.

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Organization	Goodrx
Employees	738
CEO	Ms. Wendy Barnes
Industry	Technology Services

Key Management of Goodrx Holdings, Inc.

Name	Title
Mr. Trevor Bezdek	Co-founder & Co-Chairman of the Board
Mr. Douglas Joseph Hirsch	Co-founder & Director
Mr. Romin Nabiey	Chief Accounting Officer
Ms. Wendy Barnes	President, CEO & Director
Mr. Christopher A. McGinnis	CFO & Treasurer
Mr. Nitin Shingate	Chief Technology Officer
Ms. Aubrey Reynolds	Director of Investor Relations
Ms. Gracye Cheng	Senior VP, General Counsel & Secretary
Mr. Ryan Sullivan	Chief Marketing Officer
Ms. Vina M. Leite	Chief People Officer

Important FAQs about investing in GDRX Stock from India :

What is Goodrx share price today?

Goodrx share price today is $4.36 as on August 30, 2025 at 1:29 am IST at the close of the market. Goodrx share today touched a day high of $4.36 and a low of $4.27.

What is the 52 week high and 52 week low for Goodrx share?

Goodrx share touched a 52 week high of $8.22 and a 52 week low of $3.31. Goodrx stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $4.36, lower by 46.96% versus the 52 week high.

How to invest in Goodrx Stock (GDRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Goodrx on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Goodrx Shares that will get you 0.3440 shares as per Goodrx share price of $4.36 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Goodrx Stock (GDRX) from India?

Indian investors can start investing in Goodrx (GDRX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Goodrx stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Goodrx share’s latest price of $4.36 as on August 30, 2025 at 1:29 am IST, you will get 2.2936 shares of Goodrx. Learn more about fractional shares .

What are the returns that Goodrx has given to Indian investors in the last 5 years?

Goodrx stock has given -91.38% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?